Capha Pharmaceuticals Inc. Stock

Stocks

25-07-31	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-23	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
24-10-17	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-07-29	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	2004-01-12

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	2004-01-12
Herbert Leary BRD	Director/Board Member	-	2010-10-24
James Brown CHM	Chairman	-	2002-10-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/11/21	James Brown	Free	Chief Executive Officer	888,036	1.3783%
11/11/21	Janice Brown	Free	Director	888,036	1.3783%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-99.00%	-	-	64
ELI LILLY AND COMPANY	+0.85%	-0.80%	+52.79%	+161.33%	1,051B
JOHNSON & JOHNSON	+1.23%	-1.53%	+54.58%	+59.08%	609B
ABBVIE INC.	+0.04%	+2.58%	+34.47%	+86.33%	450B
ROCHE HOLDING AG	+0.78%	-0.71%	+29.28%	+24.10%	330B
NOVARTIS AG	+1.41%	+0.58%	+35.44%	+40.67%	284B
ASTRAZENECA PLC	-0.27%	-1.87%	+22.34%	+22.51%	263B
NOVO NORDISK A/S	-1.76%	+2.37%	-20.43%	-38.00%	223B
AMGEN INC.	-1.42%	+0.80%	+24.27%	+57.50%	198B
GILEAD SCIENCES, INC.	-1.48%	+3.43%	+24.08%	+71.67%	167B
Average	-0.06%	+0.54%	+28.54%	+53.91%	397.23B
Weighted average by Cap.	+0.37%	+0.02%	+37.51%	+79.63%